^
Association details:
| Biomarker: | ALK G1202R |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Alunbrig (brigatinib) (EGFR inhibitor, ALK inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy
Excerpt:
...a patient with the recalcitrant G1202R mutation had a confirmed PR in the ALTA trial.
DOI:
10.2147/DDDT.S147499
